Skip to search.
 STI Up 0.21%

Becton, Dickinson and Company (BDX)

-NYSE
164.41 Down 1.12(0.68%) 6 Dec 05:01 SGT
Prev Close:165.53
Open:166.47
Bid:160.00 x 500
Ask:164.53 x 300
1y Target Est:188.57
Beta:0.998153
Earnings Date:1 Feb - 6 Feb (Est.)
Day's Range:163.93 - 167.08
52wk Range:129.50 - 181.76
Volume:1,599,617
Avg Vol (3m):1,060,930
Market Cap:34.91B
P/E (ttm):36.62
EPS (ttm):4.49
Div & Yield:2.92 (1.76%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BDXDown 0.68%34.91B
BAXDown 0.27%23.87B
ABTUp 1.40%56.58B

Key Statistics

Forward P/E (1 yr):15.64
P/S (ttm):2.82
Ex-Dividend Date:07-Dec-16

Analysts

Annual EPS Est (Sep-17) :9.52
Quarterly EPS Est (Dec-16) :2.12
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback